会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明专利
    • PROCESS FOR PRODUCING REBECCAMYCIN ANALOGS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SUCH ACTIVE INGREDIENT
    • HU201773B
    • 1990-12-28
    • HU516487
    • 1987-11-20
    • BRISTOL MYERS SQUIBB CO
    • KANEKO TAKUSHIWONG HENRY SUTZIG JACOB J
    • C07H19/23A61K31/70A61K31/7042A61K31/7052A61P35/00C07H19/044
    • There are disclosed analogs of the antitumor agent, rebeccamycin, having the formula wherein: n is an integer from 1 to 6; A and A are selected from H and -(CH2)nNR R and at least one of A and A is -(CH2)n-NR R ; R and R , independently, are selected from hydrogen, unsubstituted and substituted C1-C6 alkyl, aralkyl having 1 to 3 carbons in the alkyl moiety and unsubstituted phenyl or phenyl substituted with 1 to 3 alkyl, alkoxy, hydroxy, halo, carboxyl, alkoxycarbonyl, and amino and mono- and di-lower-alkylamino groups in the aryl moiety, and aryl selected from unsubstituted phenyl and phenyl substituted with 1 to 3 alkyl, alkoxy, hydroxy, halo, amino, mono- and dialkylamino, nitro, carboxyl, alkoxycarbonyl, and cyano groups provided that both R and R are not each aryl and, when taken together, R and R may be selected from -(CH2)4- and (CH2)2-R -(CH2)2- to form a 5- or 6-membered ring together with the N-atom wherein R is selected from CH2, NH, O and S; X is selected from H, F, Cl, Br, C1-C3 alkyl, OH, carboxyl, alkoxycarbonyl and alkoxy wherein the alkyl moiety is C1-C3 alkyl, benzyloxy, amino, and mono- and dialkylamino; and R is selected from H and CH3; and pharmaceutically acceptable acid addition and base salts thereof. The compounds possess antineoplastic properties against mammalian, particularly experimental animal, tumor systems. The compounds of the invention are aminoalkylated derivatives of rebeccamycin produced by first reacting rebeccamycin with a strong base to obtain a reactive intermediate and then reacting the reactive intermediate with an aminoalkyl compound.
    • 7. 发明专利
    • DE3783577D1
    • 1993-02-25
    • DE3783577
    • 1987-11-20
    • BRISTOL MYERS SQUIBB CO
    • KANEKO TAKUSHIWONG HENRY SUTZIG JACOB J
    • C07H19/23A61K31/70A61K31/7042A61K31/7052A61P35/00C07H19/044
    • There are disclosed analogs of the antitumor agent, rebeccamycin, having the formula wherein: n is an integer from 1 to 6; A and A are selected from H and -(CH2)nNR R and at least one of A and A is -(CH2)n-NR R ; R and R , independently, are selected from hydrogen, unsubstituted and substituted C1-C6 alkyl, aralkyl having 1 to 3 carbons in the alkyl moiety and unsubstituted phenyl or phenyl substituted with 1 to 3 alkyl, alkoxy, hydroxy, halo, carboxyl, alkoxycarbonyl, and amino and mono- and di-lower-alkylamino groups in the aryl moiety, and aryl selected from unsubstituted phenyl and phenyl substituted with 1 to 3 alkyl, alkoxy, hydroxy, halo, amino, mono- and dialkylamino, nitro, carboxyl, alkoxycarbonyl, and cyano groups provided that both R and R are not each aryl and, when taken together, R and R may be selected from -(CH2)4- and (CH2)2-R -(CH2)2- to form a 5- or 6-membered ring together with the N-atom wherein R is selected from CH2, NH, O and S; X is selected from H, F, Cl, Br, C1-C3 alkyl, OH, carboxyl, alkoxycarbonyl and alkoxy wherein the alkyl moiety is C1-C3 alkyl, benzyloxy, amino, and mono- and dialkylamino; and R is selected from H and CH3; and pharmaceutically acceptable acid addition and base salts thereof. The compounds possess antineoplastic properties against mammalian, particularly experimental animal, tumor systems. The compounds of the invention are aminoalkylated derivatives of rebeccamycin produced by first reacting rebeccamycin with a strong base to obtain a reactive intermediate and then reacting the reactive intermediate with an aminoalkyl compound.
    • 10. 发明专利
    • DE3783577T2
    • 1993-05-19
    • DE3783577
    • 1987-11-20
    • BRISTOL MYERS SQUIBB CO
    • KANEKO TAKUSHIWONG HENRY SUTZIG JACOB J
    • C07H19/23A61K31/70A61K31/7042A61K31/7052A61P35/00C07H19/044
    • There are disclosed analogs of the antitumor agent, rebeccamycin, having the formula wherein: n is an integer from 1 to 6; A and A are selected from H and -(CH2)nNR R and at least one of A and A is -(CH2)n-NR R ; R and R , independently, are selected from hydrogen, unsubstituted and substituted C1-C6 alkyl, aralkyl having 1 to 3 carbons in the alkyl moiety and unsubstituted phenyl or phenyl substituted with 1 to 3 alkyl, alkoxy, hydroxy, halo, carboxyl, alkoxycarbonyl, and amino and mono- and di-lower-alkylamino groups in the aryl moiety, and aryl selected from unsubstituted phenyl and phenyl substituted with 1 to 3 alkyl, alkoxy, hydroxy, halo, amino, mono- and dialkylamino, nitro, carboxyl, alkoxycarbonyl, and cyano groups provided that both R and R are not each aryl and, when taken together, R and R may be selected from -(CH2)4- and (CH2)2-R -(CH2)2- to form a 5- or 6-membered ring together with the N-atom wherein R is selected from CH2, NH, O and S; X is selected from H, F, Cl, Br, C1-C3 alkyl, OH, carboxyl, alkoxycarbonyl and alkoxy wherein the alkyl moiety is C1-C3 alkyl, benzyloxy, amino, and mono- and dialkylamino; and R is selected from H and CH3; and pharmaceutically acceptable acid addition and base salts thereof. The compounds possess antineoplastic properties against mammalian, particularly experimental animal, tumor systems. The compounds of the invention are aminoalkylated derivatives of rebeccamycin produced by first reacting rebeccamycin with a strong base to obtain a reactive intermediate and then reacting the reactive intermediate with an aminoalkyl compound.